Total intravenous anesthesia induced and maintained by a combination of remimazolam and remifentanil without a neuromuscular blocking agent: a prospective, observational pilot study

BACKGROUND: A novel short-acting benzodiazepine, Remimazolam, has recently been approved for general anesthesia and sedation. Hence, we investigated the feasibility and safety of remimazolam during the induction and maintenance of general anesthesia without using a neuromuscular blocking agent (NMBA...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Insun, Cho, Mincheul, Nam, Sun Woo, Hwang, Jung-Won, Do, Sang-Hwan, Na, Hyo-Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316331/
https://www.ncbi.nlm.nih.gov/pubmed/35883039
http://dx.doi.org/10.1186/s12871-022-01779-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316331/
https://www.ncbi.nlm.nih.gov/pubmed/35883039
http://dx.doi.org/10.1186/s12871-022-01779-2

Ejemplares similares